Pricing

CAXTON CORP

0 followers ยท
PRINCETON NJ
13F Summary
Caxton Corp is based out of Princeton. Their last reported 13F filing for Q4 2023 included $18,524,322 in managed 13F securities and a top 10 holdings concentration of 99.27%. Caxton Corp's largest holding is Xeris Biopharma Holdings Inc with shares held of 5,641,920. Whalewisdom has at least 50 13F filings, 17 13D filings, and 49 13G filings

2023-12-31

Top Buys (13F)

Name % Change
SPY SPDR S&P 500 ETF TRU 3.39%
BRK.B Berkshire Hathaway I 1.99%
ABVX Abivax 0.97%
LXEO Lexeo Therapeutics I 0.75%
HARP Harpoon Therapeutics 0.7%

2023-12-31

Top Sells (13F)

Name % Change
SVRA Savara Inc 38.62%
ACRS Aclaris Therapeutics 0.51%
CMPX Compass Therapeutics 0.28%
ALLK Allakos Inc 0.06%
ELEV Elevation Oncology I 0.05%

2023-12-31

13F Holdings Summary

Name $ Change
XERS Xeris Biopharma Hold 71.57%
SVRA Savara Inc 8.97%
RZLT Rezolute Inc 7.07%
SPY SPDR S&P 500 ETF TRU 3.39%
MTEM Molecular Templates 2.76%

Confidential Treatment - Holdings omitted in latest filing.

2023-12-31

13F Activity

Market Value $18.5m, Prior: $26.3m
New Purchases 5 stocks
Added To 0 stocks
Sold out of 2 stocks
Reduced holdings in 4 stocks
Top 10 Holdings % 99.27%
Turnover %[1] 58.33%
Turnover Alt %[2] 7.8%
Time Held Top 20 5.4167 quarters
Time Held Top 10 3.5 quarters
Time Held All 5.42 quarters

[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.

[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.

2023-12-31

13F Sector Allocation Over Time

2023-12-31

Analysis

Top 20 equal-weighted holdings. Performance numbers calculated through 2023-12-31

Portfolio Performance